MedTrace Logo

Sensitivity of ECG on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine

NCT01091766 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2012-07-24

No results posted yet for this study

Summary

The purpose of this prospective randomised study is to investigate electrocardiographic alterations after intravascular injection of three different test solutions of bupivacaine and epinephrine in anaesthetised children up to 16 years of age.

Conditions

  • Anaesthesia
  • Toxicity

Interventions

DRUG

intravenous injection of test solution

test dose consists of 0.2 ml/kg body weight test solution of the assigned drug

DRUG

intravenous injection of test solution

test dose consists of 0.2 ml/kg body weight test solution of the assigned drug

DRUG

intravenous injection of test solution

test dose consists of 0.2 ml/kg body weight test solution of the assigned drug

Sponsors & Collaborators

  • University Children's Hospital, Zurich

    lead OTHER

Principal Investigators

  • Markus Weiss, Prof · University Childrens Hospital Zurich, Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01091766 on ClinicalTrials.gov